MedPath

Food Insecurity in Oncology

Not Applicable
Completed
Conditions
Food Insecurity
Cancer
Interventions
Behavioral: Unconditional Cash Transfer (UCT)
Registration Number
NCT05176743
Lead Sponsor
New Mexico Cancer Care Alliance
Brief Summary

This trial will examine the feasibility and preliminary effectiveness of providing unconditional cash transfers to food insecure female breast and gynecologic cancer patients.

Approximately one-third of cancer survivors report food insecurity, characterized by limited access to adequate food for active, healthy living because of a lack of money and other resources. Unconditional cash transfers offer direct monetary assistance that can be used to meet immediate food or other financial needs and may positively impact health care resource utilization and health-related quality of life.

Detailed Description

In this delayed intervention trial, 44 female breast and gynecologic cancer patients experiencing food insecurity will be randomized in a 1:1 ratio to receive unconditional cash transfers (UCT) for 3 months or an equivalent one-time UCT at the end of the study.

Quantitative surveys will be administered at baseline and after 3-months. Survey measures will include questions about health care resource utilization, health-related quality of life, food security, hospitalization use, emergency department use, and mental health. The main objective for this pilot trial is to assess feasibility. The investigators will measure whether the investigators can: recruit 44 food insecure participants meeting the eligibility criteria over a 3-month recruitment window and describe the barriers and facilitators of the recruitment process. The investigators will also monitor retention and survey completion. At the end of the 3 month follow-up period, all participants will complete a semi-structured exit interview.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
44
Inclusion Criteria
  • Diagnosis of female breast (ICD-10 C50), ovarian (ICD-10 C56), endometrial (ICD-10 C54), cervical (ICD-10 C53), vulvar cancer (ICD-10 C51)
  • Diagnosed within 24-months of identification
  • Stage I-III
  • Completed initial course of cancer directed therapy (surgery, radiation, chemotherapy).
  • Age ≥18
  • Able to speak English or Spanish
  • Food insecure
Exclusion Criteria
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Prisoners

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual CareUnconditional Cash Transfer (UCT)* Referral to services * Nutrition pamphlets * One-time payment of $300 paid 4 months after baseline
Unconditional Cash Transfer InterventionUnconditional Cash Transfer (UCT)* Three monthly payments of $100 * Referral to services * Nutrition pamphlets
Primary Outcome Measures
NameTimeMethod
Determine the percentage of referred patients who are eligible to enroll in the study and choose to do so3 months
Determine the percentage of patients who complete both the baseline and 3 month follow-up survey3 months
Determine the number of participants who complete the surveys3 months
Secondary Outcome Measures
NameTimeMethod
Assess healthcare resource utilization using the PhenX-Access to Health Services toolkit3 months
Healthcare costs3 months
Determine the number of patients who use the Emergency Department during the 3 month follow-up period as well as how many visits they have3 months
Assess health-related quality of life using the PROMIS Global Health 10 item questionnaire3 months

Nine of the Global Health PROMIS measures items are scored on a Likert scale, with 1 representing the worst health situation and 5 representing the best health situation. Pain is scored from 0 to 10 with 0 indicating no pain and 10 representing the worst pain ever experienced. Two sub-scores can also be derived from the 10 item questionnaire to assess physical and mental health separately. Raw scores must be converted to a standardized T-score for interpretation. A higher PROMIS T-score indicates a person whose health is better than the average respondent.

Assess number of participants experiencing depression using the Patient Health Questionnaire (PHQ-9) screener tool3 months
Assess participants perceived self-efficacy using the PROMIS Self-Efficacy for Managing Medications and Treatments 4a questionnaire3 months

The 4 questions that comprise this measure are measured on a Likert scale with 1 representing that the respondent is "not at all confident" completing the described task and 5 representing that the respondent is "very confident" completing the task. Raw scores range from 4-20, but T-score conversions are needed for interpretation. A higher PROMIS T-score indicates a person whose health is better than the average respondent.

Determine the number of patients who report being hospitalized during the 3 month follow-up period as well as the number of times they are hospitalized3 months
Assess the number of participants who are food insecure using the Hunger VitalSign food insecurity screening tool3 months
Assess incidence of participant stress using the Perceived Stress Scale (PSS-10)3 months

Trial Locations

Locations (1)

University of New Mexico Comprehensive Cancer Center

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath